LUND, Sweden, June 18, 2025 /PRNewswire/ -- Camurus (NASDAQ STO: CAMX) today announced topline results from the 12-month, randomized, double-blind, placebo-controlled POSITANO Phase 2b study ...

Camurus, an international, science-led biopharmaceutical company, announced topline results from the 12-month, randomized, double-blind, placebo-controlled POSITANO phase 2b study (NCT05281328), ...

1 Currently, no approved treatment exists for PLD. "The POSITANO study shows that CAM2029 significantly reduces liver and liver cyst volume compared to placebo while showing improvements in ...

UPDATE, Tuesday: In the second part of a two-part GMA interview, Euphoria actor Eric Dane revealed that he is in a research study for his ALS and is taking medication to slow the effects of the ...

1 Currently, no approved treatment exists for PLD. “The POSITANO study shows that CAM2029 significantly reduces liver and liver cyst volume compared to placebo while showing improvements in symptoms ...

Inside the Race: Analyzing Shane van Gisbergen’s ‘book’ on road courses ...

‘We just won the 600!’: Chastain soaks in epic crown-jewel triumph ...

Thank you for reporting this station. We will review the data in question. You are about to report this weather station for bad data. Please select the information that is incorrect.